FDA Adverse Event Injury Summary report: N

SODIUM CHLORIDE INHALATION SOLUTION, USP, 0.9% 15ML

MDR report key: 22095307 · Received May 28, 2025

Report

Report Number
3001237796-2025-00057
Event Type
Injury
Date Received
May 28, 2025
Report Date
May 28, 2025
Manufacturer
THE RITEDOSE CORPORATION
Product Code
CAF
UDI-DI
00376204300506
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
003

Narratives

Description of Event or Problem · 0

THIS SPONTANEOUS REPORT FROM THE UNITED STATES WAS REPORTED BY A FEMALE PATIENT (UNSPECIFIED AGE) WHO USED SODIUM CHLORIDE INHALATION SOLUTION 0.9% FOR HER SCLERAL LENS AND ACANTHAMOEBA. IN AN UNSPECIFIED DATE IN 2022-2023, THE PATIENT-INITIATED TREATMENT WITH SODIUM CHLORIDE INHALATION SOLUTION, USP, 0.9% (UNSPECIFIED DOSING DETAILS) VIA THE OPHTHALMIC ROUTE FOR SCLERAL LENS. ON AN UNSPECIFIED DATE IN 2024, THE PATIENT HAD ACANTHAMOEBA PARASITE IN THE RIGHT EYE FOLLOWING SHE HAD EVISCERATION OF RIGHT EYE ON (B)(6) 2024. SHE STATED THAT SHE HAS STOPPED USING HER LENSES SINCE (B)(6) 2024. ACTION TAKEN WITH SODIUM CHLORIDE INHALATION SOLUTION WAS UNKNOWN. THE OUTCOME OF THE EVENT ACANTHAMOEBA WAS UNKNOWN. THE OUTCOME OF THE EVENT USING SODIUM CHLORIDE INHALATION SOLUTION 0.9% FOR HER SCLERAL LENS WHICH SHE GOT THROUGH DOCTOR'S PRESCRIPTION WAS NOT APPLICABLE. ADDITIONAL INFORMATION WAS RECEIVED ON 30-APR-2025: EVENT OF MISUSE UPDATED TO OFF LABEL, ADDITIONAL EVENT (ACANTHAMOEBA PARASITE IN THE RIGHT EYE), THERAPY START DATE, MEDICAL HISTORY, CONCOMITANT MEDICATIONS ADDED, AND EVENT DESCRIPTION UPDATED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
715251 SODIUM CHLORIDE INHALATION SOLUTION, USP, 0.9% 15ML NEBULIZER (DIRECT PATIENT INTERFACE) CAF THE RITEDOSE CORPORATION 24AD9 00376204300506

Patients

Seq Age Sex Outcome Treatment
1 NA Female Other CALCIUM.| FORTEO (TERIPARATIDE).| FOSAMAX (ALENDRONATE SODIUM).| VITAMIN D3.